Off-label use of drugs in Italy: a prospective, observational and multicentre study

被引:61
|
作者
Pandolfini, C [1 ]
Impicciatore, P [1 ]
Provasi, D [1 ]
Rocchi, F [1 ]
Campi, R [1 ]
Bonati, M [1 ]
机构
[1] Mario Negri Inst Pharmacol Res, Lab Mother & Child Hlth, IT-20157 Milan, Italy
关键词
children; drug labelling; Italy; multicentre study; off-label drug use;
D O I
10.1080/08035250252834030
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
The aims of the study were to measure the paediatric, off-label use of drugs in the Italian hospital setting and to reveal areas for priority intervention by investigating the therapeutic indications most involved. Prescriptions given to all children admitted to nine general paediatric hospital wards from December 1998 to February 1999 were analysed. In total, 4265 prescriptions were given to 1461 children, 10 of which were unlicensed and excluded from further analysis. Sixty percent of prescriptions (range between centres: 44-71%) were off-label and concerned 89% of children receiving medications (80-96%). The main drug classes were antibacterials, antiasthmatics and analgesics, and represented 56% of off-label prescriptions. Paracetamol (385 prescriptions) and beclomethasone (339) were the generic substances most often used off-label. The most common off-label categories were dosage/frequency (50% of prescriptions), indication and lack of paediatric licence (7% each). Fifty-four per cent 4 all indications that led to off-label prescribing involved only respiratory problems. fever, respiratory tract infections and bronchospasm. Conclusion: Despite prescription profile differences among centres, off-label use was high everywhere. Immediate action for more rational drug use is necessary and requires not only regulatory intervention but also a more evidence-based, therapeutic approach.
引用
收藏
页码:339 / 347
页数:9
相关论文
共 50 条
  • [1] Off-Label and Unlicensed Drugs in Pediatric Palliative Care: A Prospective Observational Study
    Garcia-Lopez, Isabel
    Cuervas-Mons Vendrell, Margarita
    Martin Romero, Irene
    de Noriega, Inigo
    Benedi Gonzalez, Juana
    Martino-Alba, Ricardo
    [J]. JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2020, 60 (05) : 923 - 932
  • [2] Off-label use of inhaled bronchodilators in hospitalised patients in Spain: a multicentre observational study
    Villamanan, Elena
    Sobrino, Carmen
    Bilbao, Cristina
    Fernandez, Jaime
    Herrero, Alicia
    Calle, Myriam
    Alvaro, Dolores
    Segura, Maria
    Picazo, Gracia
    Miguel Rodriguez, Jose
    Baldominos, Gema
    Teresa Ramirez, Maria
    Larrubia, Yolanda
    Llorente, Jesus
    Martinez, Alicia
    Alvarez-Sala, Rodolfo
    [J]. EUROPEAN JOURNAL OF HOSPITAL PHARMACY, 2021, 28 (E1) : E23 - E28
  • [3] The ethics of off-label use of drugs: oncology pharmacy in Italy
    Bernardi, A.
    Pegoraro, R.
    [J]. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2008, 33 (02) : 95 - 99
  • [4] Off-label prescription of antineoplastic drugs: A prospective, observational, multicenter survey
    Roila, Fausto
    Ballatori, Enzo
    Labianca, Roberto
    De Braud, Filippo
    Borgonovo, Karen
    Martelli, Olga
    Gallo, Ciro
    Perrone, Francesco
    [J]. ANNALS OF ONCOLOGY, 2007, 18 : 87 - 87
  • [5] The use of "off-label"' drugs
    Broadman, LM
    Semenov, I
    [J]. ANESTHESIA AND ANALGESIA, 2006, 103 (01): : 250 - 251
  • [6] Off-label prescription of antineoplastic drugs: an Italian prospective, observational, multicenter survey
    Rolla, Fausto
    Ballatori, Enzo
    Labianca, Roberto
    De Braud, Filippo
    Borgonovo, Karen
    Martelli, Olga
    Gallo, Ciro
    Tinazzi, Angelo
    Perrone, Francesco
    [J]. TUMORI JOURNAL, 2009, 95 (06): : 647 - 651
  • [7] Paediatric off-label use of drugs in Gansu, China: a multicentre cross-sectional study
    Meng, Min
    Ge, Bin
    Lei, Wenjuan
    Wu, Yuqiong
    Tian, Min
    Lu, Yali
    Shao, Tingji
    Yang, Yan
    Luo, Xufei
    Luo, Jiawei
    Gao, Yang
    Li, Qiu
    Chen, Yaolong
    [J]. BMJ OPEN, 2024, 14 (05):
  • [8] Off-label use of approved drugs
    Landow, L
    [J]. CHEST, 1999, 116 (03) : 589 - 591
  • [9] Controlled use of off-label drugs
    Seeber, S
    [J]. EUROPEAN JOURNAL OF CANCER, 2003, 39 (09) : 1189 - 1189
  • [10] Guidance for off-label use of drugs
    不详
    [J]. LANCET NEUROLOGY, 2008, 7 (04): : 285 - 285